These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18267336)

  • 1. Effect of BMI on primary treatment of prostate cancer.
    Davies BJ; Walsh TJ; Ross PL; Knight SJ; Sadetsky N; Carroll PR; Kane CJ
    Urology; 2008 Aug; 72(2):406-11. PubMed ID: 18267336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
    Efstathiou JA; Chen MH; Renshaw AA; Loffredo MJ; D'Amico AV
    Cancer; 2007 Apr; 109(8):1493-8. PubMed ID: 17340594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
    Tsai HK; Chen MH; McLeod DG; Carroll PR; Richie JP; D'Amico AV
    Cancer; 2006 Dec; 107(11):2597-603. PubMed ID: 17039498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
    Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
    Meng MV; Elkin EP; Latini DM; Duchane J; Carroll PR
    J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
    Palma D; Pickles T; Tyldesley S;
    BJU Int; 2007 Aug; 100(2):315-9. PubMed ID: 17617138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
    Pfitzenmaier J; Pritsch M; Haferkamp A; Jakobi H; Fritsch F; Gilfrich C; Djakovic N; Buse S; Pahernik S; Hohenfellner M
    BJU Int; 2009 Apr; 103(7):877-82. PubMed ID: 19007372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
    van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
    BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.
    van Roermund JG; Hinnen KA; Battermann JJ; Witjes JA; Bosch JL; Kiemeney LA; van Vulpen M
    BJU Int; 2010 Jan; 105(1):42-8. PubMed ID: 19519759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Barry MJ; Stanford JL; Hamilton AS; Hunt WC; Collins MM
    Am J Med; 2006 May; 119(5):418-25. PubMed ID: 16651054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.